The story of Viagra, and its developer copyright, presents a challenging case study for investors. At first a blockbuster drug, yielding billions in sales , its patent expiration created a flood of knock-off medications, significantly impacting its dominance. While some businesses may attempt to capitalize on male sexual dysfunction, the existing l